Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate to Severe Refractory Autoimmune Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 7 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07678645
What this trial is testing

The Safety and Efficacy of Upadacitinib in Refractory Autoimmune Related Cholangitis and Atopic Dermatitis With Moderate to Severe Itching

Who this might be right for
Primary Biliary Cholangitis (PBC)Primary Sclerosing Cholangitis (PSC)Atopic Dermatitis (AD)
RenJi Hospital 44
Very early researchLooking for participantsNCT07614191
What this trial is testing

A Clinical Study to Evaluate the Safety and Efficacy of GT801 Injection in the Treatment of Moderate to Severe Refractory Autoimmune Diseases

Who this might be right for
Moderate to Severe Refractory Autoimmune Diseases
Vivacta Biotechnology (Shanghai) Co., Ltd. 22
Very early researchLooking for participantsNCT07001956
What this trial is testing

The Clinical Study on the Treatment of Refractory RA With UTAA91 Injection

Who this might be right for
Rheumatoid Arthritis (RA)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 24
Testing effectiveness (Phase 2)Looking for participantsNCT06721962
What this trial is testing

Treatment of Moderate to Severe Refractory Crohn's Disease

Who this might be right for
Crohns Disease
Tr1X, Inc. 39
Testing effectiveness (Phase 2)Looking for participantsNCT07570862
What this trial is testing

A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis

Who this might be right for
Lupus NephritisSystemic Lupus ErythematosusSLE - Systemic Lupus Erythematosus+2 more
Fate Therapeutics 53
Early research (Phase 1)Looking for participantsNCT07219563
What this trial is testing

Alnuctamab for Refractory SLE (LATTE Study)

Who this might be right for
Systemic Lupus Erythematosus
Icahn School of Medicine at Mount Sinai 21
Early research (Phase 1)Not Yet RecruitingNCT06468683
What this trial is testing

F01 in the Treatment of Moderate-to-severe Refractory Systemic Lupus Erythematosus

Who this might be right for
Lupus Erythematosis
Shanghai Simnova Biotechnology Co.,Ltd. 50